BioSpace News Archive

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced participation in the following investor conferences in September.

Brazil is the first Latin American country to now welcome Tru Niagen®, with a strategy focused on reaching both consumers and Health Care Practitioners ChromaDex Corp. announced a partnership with MyPharma2Go to conduct cross-border sales of Tru Niagen® and Tru Niagen® PRO in Brazil, the first Latin American country to welcome the brand.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, announced that senior management will present at the following upcoming investor conferences.

Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical products, announced that it recently submitted an application to the Centers for Medicare & Medicaid Services for a unique HCPCS billing code for its AC5® Advanced Wound System.

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on August 30, 2022, the Canadian Agency for Drugs and Technologies in Health (CADTH) Canadian Drug Expert Committee (CDEC) recommended VABYSMO® (faricimab injection) for public reimbursement.

Bio-Techne Corporation announced its plan to request shareholder approval during its upcoming 2022 Annual Meeting of Shareholders for an increase in the total number of authorized shares of common stock through an amendment to the Company’s Articles of Incorporation to implement a four-for-one forward stock split in the form of a stock dividend.

Centene Corporation announced the appointment of Ashlee Knuckey as Chief Ethics and Compliance Officer.

Zimmer Biomet Holdings, Inc., a global medical technology leader, announced an exclusive, multi-year co-marketing agreement with Surgical Planning Associates, Inc. to commercialize HipInsight™, the first FDA-cleared mixed reality navigation system for total hip replacement.

Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, announced outstanding outcomes for the Galen™ Breast solution in diagnosing multiple cancer types and further expansion of its AI portfolio for breast cancer diagnosis.

Ginkgo Bioworks, the leading horizontal platform for cell programming, announced that Behzad Mahdavi, Ph.D., MBA, has joined as senior vice president of biopharma manufacturing and life sciences tools.